Aberrant DNA methylation associated with MTHFR C677T genetic polymorphism in cutaneous squamous cell carcinoma in renal transplant patients.
AffiliationDepartment of Dermatology, RCSI ERC Smurfit Building, Beaumont Hospital, Dublin 9, Ireland. firstname.lastname@example.org
Aged, 80 and over
Carcinoma, Squamous Cell
Methylenetetrahydrofolate Reductase (NADPH2)
Sequence Analysis, DNA
MetadataShow full item record
CitationAberrant DNA methylation associated with MTHFR C677T genetic polymorphism in cutaneous squamous cell carcinoma in renal transplant patients. 2010, 163 (2):345-52 Br. J. Dermatol.
JournalThe British journal of dermatology
AbstractChanges in genomic DNA methylation associated with cancer include global DNA hypomethylation and gene-specific hyper- or hypomethylation. We have previously identified a genetic variant in the MTHFR gene involved in the methylation pathway which confers risk for the development of squamous cell carcinoma (SCC) in renal transplant patients. This genetic variant has also been discovered to confer SCC risk in nontransplant patients with low folate status.
To explore the methylation profile of SCC compared with adjacent non-neoplastic skin using pyrosequencing, and to elucidate whether the MTHFR polymorphism impacts upon the methylation patterns in SCC.
We used pyrosequencing to evaluate global (using long interspersed nuclear element 1) and gene-specific (p16 and MGMT) methylation status in 47 SCCs and 40 adjacent autologous non-neoplastic skin samples in those with (n = 16) and without (n = 17) the MTHFR polymorphism.
Pyrosequencing methylation analysis revealed that SCC was hypomethylated compared with adjacent non-neoplastic skin (P < 0.04). Patients with the MTHFR polymorphism had higher levels of global methylation in tumours and non-neoplastic skin compared with those without the MTHFR polymorphism (P < 0.002). There was no association between levels of methylation in tumour and non-neoplastic skin for the genes MGMT and p16.
Global hypomethylation appears to be a feature of SCC. Aberrant methylation of DNA appears related to polymorphisms of MTHFR. Such findings suggest that intervention in the form of demethylating agents or folate supplementation might be beneficial in the treatment or prevention of SCC.
- [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
- Authors: Xue HC, Wang JM, Xu B, Guo GP, Hua ZL, Zhou Q, Zhu ZH, Ma ZK, Gao J
- Issue date: 2008 Dec
- Association of methylenetetrahydrofolate reductase polymorphism and the risk of squamous cell carcinoma in renal transplant patients.
- Authors: Laing ME, Dicker P, Moloney FJ, Ho WL, Murphy GM, Conlon P, Whitehead AS, Shields DC
- Issue date: 2007 Jul 15
- Interaction between the MTHFR C677T polymorphism and alcohol--impact on oral cancer risk and multiple DNA methylation of tumor-related genes.
- Authors: Supic G, Jovic N, Kozomara R, Zeljic K, Magic Z
- Issue date: 2011 Jan
- Polymorphisms in the MTHFR and VDR genes and skin cancer risk.
- Authors: Han J, Colditz GA, Hunter DJ
- Issue date: 2007 Feb
- Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
- Authors: Siraj AK, Ibrahim M, Al-Rasheed M, Bu R, Bavi P, Jehan Z, Abubaker J, Murad W, Al-Dayel F, Ezzat A, El-Solh H, Uddin S, Al-Kuraya K
- Issue date: 2007 Dec